EATONTOWN, N.J., March 3 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE), a leader in the emerging field of biologic solutions for
regenerative medicine, announced today that Sam Owusu-Akyaw, Osteotech's
President and Chief Executive Officer, will present at the Canaccord Adams'
Small-Cap Orthopedics Conference at the Mission Bay Conference Center at
UCSF in San Francisco. Mr. Owusu-Akyaw is scheduled to present at 3:10 p.m.
Pacific Time on Tuesday, March 4, 2008.
A live, listen-only webcast of the conference presentation will be
available at our investor site at http://www.osteotech.com on the Financial
Highlights page. A replay of the conference presentation will be available
at the Company's website until March 18, 2008.
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global
leader in providing OsteoBiologic solutions for regenerative medicine to
support surgeons and their patients in the repair of the musculoskeletal
system through the development of innovative therapy-driven products that
alleviate pain, promote biologic healing and restore function. For further
information regarding Osteotech, this press release or the conference
presentation, please go to Osteotech's website at http://www.osteotech.com.
SOURCE Osteotech, Inc.
 back to top
Related links:
http://www.osteotech.com
http://www.prnewswire.com/comp/668050.html /
CONTACT:
Mark H. Burroughs of Osteotech, Inc.,
+1-732-542-2800
|
